Rate My Professor Haxby Abbott

His research program centers on musculoskeletal clinical epidemiology, health services research, and biostatistics in rehabilitation sciences, with emphasis on the management of common musculoskeletal conditions, particularly osteoarthritis of the hip and knee. Prominent initiatives include the MOA randomised controlled trial assessing the clinical and cost-effectiveness of manual therapy and exercise for osteoarthritis, the establishment of the Joint Clinic for non-surgical osteoarthritis management funded by the National Health Board, and studies on clinimetric properties of outcome measures, validity of clinical tests, and interventions for low back pain and plantar heel pain. Funded by entities such as the Health Research Council of New Zealand, Abbott's contributions extend to national leadership as OARSI National Ambassador for New Zealand, project lead for the GLA:D New Zealand programme, and co-authorship of the 2019 OARSI osteoarthritis treatment guidelines. Key publications feature "Manual therapy, exercise therapy, or both, in addition to usual care, for osteoarthritis of the hip or knee: a randomized controlled trial. 1: clinical effectiveness" (2013), its economic evaluation (2013), and "The Incremental Effects of Manual Therapy or Booster Sessions in Addition to Exercise Therapy for Knee Osteoarthritis: A Randomized Clinical Trial" (2015). Awards recognizing his impact include the Carl Smith Medal and Rowheath Trust Award (2014), University of Otago Early Career Award for Distinction in Research (2012), and Sir Charles Hercus Health Research Fellowship (2010).